Medical device maker DexCom announced Tuesday that the company has received a de novo clearance from the FDA to sell its latest continuous glucose monitoring system — the G6 — that requires no ...

First-ever automated insulin delivery with the tubeless Omnipod Insulin Management System and personal smartphone control Initially compatible with Dexcom G6 CGM, with no fingersticks* required ...

Abbott announced Thursday that its continuous glucose monitoring system, requiring no routing fingerstick calibration for type 1 diabetes patients, will now be available to eligible Medicare patients.

Nov 16 (Reuters) - DexCom Inc said it has received approval to calibrate its seven-day continuous glucose monitoring system using any blood glucose meter cleared by the Food and Drug Administration.

Dexcom CGM use is proven to improve glycemic control 1,2 and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 3 BURNABY, British ...